GlaxoSmithKline | GSK - القيمة السوقية





القيمة السوقية تغيير تاريخ
AbbVie USD 384.69B 19.14B 2026-03
Alcon AG USD 37.06B 5.98B 2026-03
Almirall EUR 2.76B 472.53M 2025-12
Amgen USD 189.89B 13.64B 2026-03
argenx SE USD 47.6B 10.03B 2026-07
AstraZeneca USD 301.25B 13.1B 2026-03
Bayer EUR 38.69B 2.33B 2026-03
Biogen USD 26.9B 1.09B 2026-03
Bristol-Myers Squibb USD 123.83B 14.02B 2026-03
Eli Lilly USD 869.02B 146.97B 2026-03
Fresenius Medical Care EUR 11.32B 642.58M 2026-03
Genmab DKK 20.48B 1.02B 2025-12
Gilead Sciences USD 172.99B 20.71B 2026-03
GlaxoSmithKline GBP 83.8B 9.44B 2026-03
Glaxosmithkline GBP 108.55B 736M 2026-07
Hikma Pharmaceutical USD 4.63B 1.42B 2025-12
Lakefront Biotherapeutics EUR 1.73B 119.93M 2026-03
Lonza CHF 39.68B 980.61M 2025-06
Merck EUR 46.78B 6.52B 2026-03
Merck USD 297.1B 35.84B 2026-03
Novartis USD 257.14B 50.62B 2026-07
Novo Nordisk A/S DKK 1.03T 421.31B 2026-03
Orion EUR 7.95B 2.2B 2026-07
Pfizer USD 153.81B 12.24B 2026-03
Philips EUR 22.47B 96.29M 2026-03
Recordati EUR 10.26B 104.56M 2026-03
Regeneron Pharmaceuticals USD 81.68B 560M 2026-03
Roche Holding CHF 266.34B 55.46B 2025-12
Sanofi EUR 100.27B 605.48M 2026-03
Smith & Nephew USD 3.47B 9.85B 2026-07
UCB EUR 46.41B 13.94B 2025-12